Pembrolizumab plus axitinib: another step ahead in advanced renal cell carcinoma Comment

Procopio Giuseppe; Nichetti Federico; Verzoni Elena

首页> 外文期刊>The lancet oncology >Pembrolizumab plus axitinib: another step ahead in advanced renal cell carcinoma Comment

【24h】

Pembrolizumab plus axitinib: another step ahead in advanced renal cell carcinoma Comment

机译：Pembrolizumab Plus Axitinib：晚期肾细胞癌评论前方的另一步

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The lancet oncology》 |2020年第12期|共2页
作者
Procopio Giuseppe; Nichetti Federico; Verzoni Elena;
展开▼
作者单位

Fdn IRCCS Ist Nazl Tumori Dept Med Oncol I-20133 Milan Italy;

Fdn IRCCS Ist Nazl Tumori Dept Med Oncol I-20133 Milan Italy;

Fdn IRCCS Ist Nazl Tumori Dept Med Oncol I-20133 Milan Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Safety of axitinib and sorafenib monotherapy for patients with renal cell carcinoma: a meta-analysis [J] . Fei Qin, Hao Yu, Changrong Xu, 生物医学研究杂志（英文版） . 2018,第001期
2. Safety of axitinib and sorafenib monotherapy for patients with renal cell carcinoma：a meta-analysis [J] . Fei Qin, Hao Yu, Changrong Xu, 生物医学研究杂志：英文版 . 2018,第001期
3. A randomized controlled trial of postoperative tumor lysate-pulsed dendritic cells and cytokine-induced killer cells immunotherapy in patients with localized and locally advanced renal cell carcinoma [J] . ZHAN Hai-lun, GAO Xin, PU Xiao-yong, 中华医学杂志（英文版） . 2012,第021期
4. Analyses of Potential Predictive Markers and Response to Targeted Therapy in Patients with Advanced Clear-cell Renal Cell Carcinoma [J] . Yan Song, Jing Huang, Ling Shan, 中华医学杂志（英文版） . 2015,第015期
5. Cost-Effectiveness of Pembrolizumab plus Axitinib Versus Sunitinib as First-Line Therapy in Advanced Renal Cell Carcinoma in the U.S. [J] . Dong Ding, Huabin Hu, Yin Shi, The oncologist . 2021,第2期

机译：Pembrolizumab Plus Axitinib与Sunitinib的成本效益作为美国晚期肾细胞癌中的一线治疗。
6. Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial [J] . Atkins Michael B., Plimack Elizabeth R., Puzanov Igor, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2021,第1期

机译：Axitinib Plus Pembrolizumab患者晚期肾细胞癌：IB审判中的长期疗效和安全性
7. Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma [J] . Martina Spisarová, Bohuslav Melichar, Denisa Vitásková, Future oncology . 2021,第3期

机译：Pembrolizumab Plus Axitinib组合和范式改变治疗晚期肾细胞癌
8. Integration of Surgery and Systemic Therapy in the Treatment of Locally Advanced and Metastatic Renal Cell Carcinoma [C] . Christopher G. Wood Genitourinary Cancers Symposium . 2011

机译：外科和全身治疗在局部晚期和转移性肾细胞癌中的整合
9. Renal Cell Carcinoma in End Stage Renal Disease Patients: An Institutional Review [D] . Nolte, Adam. 2019

机译：肾细胞癌在末期肾病患者：制度综述
10. The efficacy and safety of the combination of axitinib and pembrolizumab‐activated autologous DC‐CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study [O] . Meng‐Jia Song, Qiu‐Zhong Pan, Ya Ding, 2021

机译：Axitinib和Pembrozumab-活化的自体DC-CIK细胞免疫治疗疗效和安全性的疗效和安全性肾细胞癌的患者：2阶段研究
11. Pembrolizumab plus axitinib and nivolumab plus ipilimumab as first-line treatments of advanced intermediate- or poor-risk renal-cell carcinoma: a number needed to treat analysis from the Brazilian private perspective [O] . Tobias Engel Ayer Botrel, Márcia Datz Abadi, Laura Chabrol Haas, 2021

机译：Pembrolizumab Plus Axitinib和Nivolumab加IpiLimumab作为先进的中间体或贫瘠风险肾细胞癌的一线治疗：从巴西私人视角治疗分析所需的数量
12. Effects of Tobacco Smoke (TS) on Growth of Clear Cell Renal Cell Carcinoma (ccRCC). [R] . Czyzyk-Krzeska, M. F. 2015

机译：烟草烟雾（Ts）对透明细胞肾癌细胞（ccRCC）生长的影响。

Pembrolizumab plus axitinib: another step ahead in advanced renal cell carcinoma Comment

著录项

相似文献

相关主题

期刊订阅